ArticleJPGN reports2025
Avoidant and restrictive food intake disorder among children with eosinophilic esophagitis.
Article in JPGN reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Avoidant-Restrictive Food Intake Disorder in Patients With Gastrointestinal Disorders: A Systematic Review.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026Pooled it
- Review
- Prevalence of Avoidant/Restrictive Food Intake Disorder (ARFID) in children with and without food allergy.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026Article
- High prevalence of avoidant/restrictive food ıntake disorder and psychiatric comorbidities in pediatric eosinophilic esophagitis.European journal of pediatrics · 2026Article
- Avoidant and restrictive food intake disorder among children with eosinophilic esophagitis.JPGN reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Children with eosinophilic esophagitis (EoE) may be at heightened risk for developing the eating disorder avoidant/restrictive food intake disorder (ARFID). However, relatively few studies have specifically looked at the prevalence of ARFID in children with EoE. The literature is plagued by varying diagnostic nomenclatures; existing studies have widely variable definitions of both ARFID and EoE. Finally, differentiating symptoms of EoE from those of ARFID can be challenging. The current study describes ARFID and its correlates in children ages 1-18 referred to a speciality EoE clinic. Methods: One hundred and fifteen children participated in an observational, pilot study. All had confirmed diagnoses of EoE and were referred to a multidisciplinary EoE clinic for ongoing care. All completed questionnaires were collected at the time of the clinic visit. Results: Thirty-seven percent of patients met criteria for ARFID based on the Eating Disorders in Youth-Questionnaire and clinical interview. Seventy percent of children who were on food elimination only met criteria for ARFID, compared to 36% on medication only and 37% on combined food elimination and medication for EoE treatment. Children with food fussiness, a greater number of immunoglobulin E-mediated food allergies, and low enjoyment of food were more likely to have a comorbid ARFID diagnosis. Youth with EoE and ARFID had a lower quality of life. Conclusions: A significant percentage of children with EoE referred to a multidisciplinary clinic struggle with the comorbid eating disorder ARFID. Routine screening and assessment should be considered to ensure adequate identification and intervention for this specific eating disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.